IL6 and neoplasm: IL-6 trans-signaling represents the circulating complex IL-6/IL-6Rα binding to the ubiquitous membrane gp130 signal transducer, and it has been shown to contribute to anti-tumor adaptive immunity by guiding lymphocyte trafficking to lymph nodes and tumors.